Miha Zabret, Marc Remacle, Maja Sereg Bahar, Ales Groselj
{"title":"Erratum: Impact of resection depth on voice outcomes following transoral laser microsurgery for early glottic lesions.","authors":"Miha Zabret, Marc Remacle, Maja Sereg Bahar, Ales Groselj","doi":"10.2478/raon-2026-0064","DOIUrl":"https://doi.org/10.2478/raon-2026-0064","url":null,"abstract":"","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Long-term outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a 15-year national referral centre experience.","authors":"Rok Petric, Gasper Pilko","doi":"10.2478/raon-2026-0054","DOIUrl":"https://doi.org/10.2478/raon-2026-0054","url":null,"abstract":"<p><strong>Background: </strong>Pseudomyxoma peritonei (PMP) is a rare peritoneal malignancy most commonly originating from appendiceal mucinous neoplasms. Cytoreductive surgery (CRS) combined with has become the standard treatment for selected patients; however, evidence is largely based on retrospective single-centre series. We report the 15-year experience of the Slovenian National Referral Centre and evaluate long-term survival and prognostic factors following CRS and hyperthermic intraperitoneal chemotherapy (HIPEC).</p><p><strong>Patients and methods: </strong>This retrospective study included all consecutive patients who underwent CRS and HIPEC for PMP between 2009 and 2024. Clinical, pathological, operative and follow-up data were prospectively collected and retrospectively analysed. Overall survival (OS) was the primary endpoint, while disease-free survival (DFS), postoperative morbidity and prognostic factors were secondary endpoints. Survival was analysed using the Kaplan-Meier method. Prognostic factors were evaluated using univariate and multivariate Cox regression analyses.</p><p><strong>Results: </strong>Thirty-seven patients underwent CRS and HIPEC during the study period. The mean Peritoneal Cancer Index (PCI) was 17.2, and complete cytoreduction (CC-0/1) was achieved in 34 patients (91.9%). Major postoperative complications (Clavien-Dindo grade III-IV) occurred in seven patients (18.9%), while no 30-day postoperative mortality was observed. After a median follow-up of 68 months, the estimated 5-year and 10-year overall survival rates were 91.9% and 83.7%, respectively. Patients with a PCI ≤12 demonstrated significantly better overall survival than those with a PCI > 12 (log-rank p = 0.028). Multivariable analysis identified achievement of complete cytoreduction (CC-0/1) and elevated preoperative Carbohydrate Antigen 19-9 (CA19-9) as independent prognostic factors for overall survival.</p><p><strong>Conclusions: </strong>CRS combined with HIPEC provides excellent long-term oncological outcomes with acceptable morbidity for patients with PMP when performed in a specialized national referral centre. Complete cytoreduction remains the principal determinant of survival, while preoperative CA19-9 provides additional prognostic information. These findings support continued centralization of PMP treatment for this rare disease.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149272856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Miha Zabret, Marc Remacle, Maja Sereg Bahar, Ales Groselj
{"title":"Impact of resection depth on voice outcomes following transoral laser microsurgery for early glottic lesions.","authors":"Miha Zabret, Marc Remacle, Maja Sereg Bahar, Ales Groselj","doi":"10.2478/raon-2026-0052","DOIUrl":"10.2478/raon-2026-0052","url":null,"abstract":"<p><strong>Background: </strong>To compare voice quality in patients undergoing the most conservative transoral laser microsurgery (TLM) types classified as type I (subepithelial mucosal resection), versus complete removal of the vocal ligament and/ or part of the vocal muscle (type II/III cordectomy).</p><p><strong>Patients and methods: </strong>Between 2021 and 2024, 65 patients with limited, clinically suspicious vocal fold lesions were included in a single-centre, prospective longitudinal study. Among them, 29 were diagnosed with high-grade intraepithelial neoplasia or early-stage glottic carcinoma (Tis/T1a) and were treated with TLM. Patients were divided into two groups: Group 1 (n = 13) included patients after type I cordectomy, and Group 2 (n = 16) included patients after type II/III cordectomy. Subjective and objective voice outcomes were assessed pre-treatment and at 1, 3, and 12 months post-treatment.</p><p><strong>Results: </strong>At 12 months, both groups demonstrated comparably favourable subjective voice outcomes, although recovery was slower in Group 2. Perceptual analysis revealed poorer voice quality up to 6 months, followed by improvement in both groups at 12 months. Videostroboscopy showed progressive improvement in vibratory function only in Group 1. Acoustic measures in Group 1 demonstrated normalisation of F0 and the s/z ratio, while jitter and shimmer remained relatively stable and mean intensity remained unchanged. In Group 2, jitter, shimmer, VTI, and the s/z ratio remained elevated at 12 months, with more frequent scarring and presence of muscle tension dysphonia.</p><p><strong>Conclusions: </strong>Objective voice measures demonstrated faster postoperative recovery in Group 1, whereas subjective voice outcomes improved substantially in both groups by 12 months.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149272872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anze Lecnik, Ziga Samsa, Borut Hribernik, Janez Ravnik
{"title":"Retrospective review of traumatic brain injury: is skull X-ray still clinically relevant?","authors":"Anze Lecnik, Ziga Samsa, Borut Hribernik, Janez Ravnik","doi":"10.2478/raon-2026-0053","DOIUrl":"https://doi.org/10.2478/raon-2026-0053","url":null,"abstract":"<p><strong>Background: </strong>Head computed tomography (CT) is the gold standard imaging modality for the evaluation of head injury. Skull radiography is no longer recommended in current guidelines due to its limited diagnostic value. Despite this, skull X-ray continues to be used in clinical practice. This study aimed to evaluate the diagnostic performance of skull X-ray and its association with intracranial injury.</p><p><strong>Patients and methods: </strong>We conducted a retrospective study of 12,392 patient encounters with head injury at a single centre between 2018 and 2023. We analysed imaging utilization and findings. Diagnostic performance of skull X-ray was assessed in 759 cases where both X-ray and CT were performed. CT served as the reference standard. Sensitivity, specificity, predictive values, and associations with intracranial haemorrhage were calculated.</p><p><strong>Results: </strong>Most X-rays were without a fracture (97.0 %). Skull X-ray demonstrated low sensitivity (43.6 %) and high specificity (91.4 %) for detecting skull fractures. Intracranial haemorrhage was present in 13.3 % of cases and occurred in 11.2 % of patients without a fracture on X-ray. Notably, 14.2 % of all CT scans (441 of 3,103) showed haemorrhage without fracture. Fracture on X-ray was associated with increased risk of intracranial haemorrhage (Odds Ratio [OR] 2.85, 95 % Confidence Interval [CI] 1.74-4.68). Clinically significant traumatic brain injury (csTBI) occurred in 17 of 759 encounters (2.2 %), with 12 admissions to intensive care unit, 10 neurosurgical interventions and 8 deaths after head injury. However, the association was not statistically significant (OR 2.64, 95 % CI 0.91-7.67, p = 0.075).</p><p><strong>Conclusions: </strong>Skull radiography has limited diagnostic value, fails to detect intracranial injury and may provide false reassurance in a clinical setting. CT remains the preferred imaging modality, and routine use of skull X-ray should be reconsidered.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149272800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Igor Rigler, Tina Gspan, Alja Longo, Janja Pretnar Oblak
{"title":"Erratum: Visual versus automated CT perfusion for outcome prediction in anterior circulation stroke treated with mechanical thrombectomy.","authors":"Igor Rigler, Tina Gspan, Alja Longo, Janja Pretnar Oblak","doi":"10.2478/raon-2026-0056","DOIUrl":"https://doi.org/10.2478/raon-2026-0056","url":null,"abstract":"","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Radiology and OncologyPub Date : 2026-09-07eCollection Date: 2026-09-01DOI: 10.2478/raon-2026-0051
Giulia Bertino, Marta Minuti, Julie Gehl, Erika Kis, Hadrian Nassabi, Michele Pio Grieco, Giuseppe Riva, Matteo Mascherini, Francesca De Terlizzi, Maja Cemazar, Gregor Sersa
{"title":"Electrochemotherapy for cutaneous tumors combined with tumor irradiation before or after treatment: feasibility, safety, and effectiveness.","authors":"Giulia Bertino, Marta Minuti, Julie Gehl, Erika Kis, Hadrian Nassabi, Michele Pio Grieco, Giuseppe Riva, Matteo Mascherini, Francesca De Terlizzi, Maja Cemazar, Gregor Sersa","doi":"10.2478/raon-2026-0051","DOIUrl":"10.2478/raon-2026-0051","url":null,"abstract":"<p><strong>Background: </strong>Electrochemotherapy (ECT) can be performed on tumors in patients that precedes tumor irradiation or on recurrent tumors after tumor irradiation. In this study we evaluated the feasibility, safety and effectiveness of the combined ECT and tumor irradiation (radiotherapy, RT) on different tumors in the head and neck region.</p><p><strong>Patients and methods: </strong>For the present cohort analysis, patients were selected from the Insp-ECT database, based on the following criteria: presence of head and neck lesions of any histological origin, treatment with both ECT and RT in any sequence, and a maximum interval of 12 months between the two treatments. The patients were treated with ECT followed by RT (ECT → RT) or RT followed by ECT (RT → ECT), in both cases because the first treatment resulted in incomplete response or subsequent relapse. In the case of ECT → RT the meantime interval was 5.7 months and in the case of RT → ECT 7.6 months. The minimal time interval between the treatments was 1 month.</p><p><strong>Results: </strong>Treatment with ECT with bleomycin was feasible in all patients, treated either before or after RT. Included were 37 patients with the head and neck lesions. The combined treatment was performed predominantly on older population of patients with the age range from 50 to 96 years, median over 80 years. Importantly, in the group ECT → RT the major reason for RT was partial response (67%) after ECT. While, in the RT → ECT group the major reason for subsequent ECT was 58% of stable or progressive disease (failure to treatment). In both groups local symptoms decreased, like ulceration, odour and suppuration of tumors. In the ECT → RT group, the short-term response after 2 months was high, with 89% objective responses. In contrast, the RT → ECT group had a significantly lower rate, with 58% objective responses. At 24-month progression free survival (PFS) was 68% in the ECT → RT group and 20% in the RT → ECT group (p = 0.0101). The overall progression free survival Kaplan-Meier curves also differed significantly (log-rank p = 0.0232).</p><p><strong>Conclusions: </strong>The combined treatment of ECT and RT is feasible, safe, and effective in elderly patients. The findings suggest that ECT may have particular value as a neoadjuvant treatment before RT, especially for bulky, ulcerated, or symptomatic lesions in this population.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"427-435"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13554300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148912417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Radiology and OncologyPub Date : 2026-09-07eCollection Date: 2026-09-01DOI: 10.2478/raon-2026-0036
Ana Perpar, Petra Georg, Ajra Secerov Ermenc
{"title":"The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.","authors":"Ana Perpar, Petra Georg, Ajra Secerov Ermenc","doi":"10.2478/raon-2026-0036","DOIUrl":"10.2478/raon-2026-0036","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer is a common malignancy. Advancements in multimodality treatment have improved outcomes. About 2-10% of patients will have a local recurrence even after optimal treatment. Salvage surgical treatment is the treatment of choice, however, in posterior and lateral recurrences, surgery is linked to a high rate of treatment-related morbidity. Some recurrences remain unresectable even after neoadjuvant treatment.</p><p><strong>Materials and methods: </strong>A systematic literature review was performed to search for studies on curative-intent radiation therapy (RT) with photons, stereotactic body radiation therapy (SBRT) and particle beam therapy. The aim of the literature search was to define the role of particle therapy in the treatment of patients with unresectable or inoperable local recurrences of rectal cancer where neoadjuvant treatment is unlikely to result in downstaging, leaving patients with RT as the only curative treatment option.</p><p><strong>Results: </strong>32 studies which fulfil the criteria were identified. In general, SBRT and particle beam therapy permitted the application of significantly higher doses to the target without a concomitant increase in treatment-related toxicities.</p><p><strong>Conclusions: </strong>For unresectable and inoperable locally recurrent rectal cancer ablative radiotherapy techniques such as SBRT and particle beam therapy offer a curative treatment approach as an alternative to surgery. SBRT can be offered for small local and nodal recurrences, while particle beam therapy can be offered for larger recurrences and complex shapes spanning several anatomical compartments as well. Further research is needed to stratify patients according to their need and eligibility for the different possible modalities of curative-intent RT.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"323-331"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548680/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148901079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Radiology and OncologyPub Date : 2026-09-07eCollection Date: 2026-09-01DOI: 10.2478/raon-2026-0047
Milica Kotur, Strahinja Odalovic, Jelena Petrovic, Nikola Pantic, Isidora Grozdic Milojevic, Dragana Sobic Saranovic, Predrag Sabljak, Vera Artiko
{"title":"<sup>18</sup>F-FDG PET/CT-based recurrence patterns and survival outcomes in esophageal carcinoma: a single center experience.","authors":"Milica Kotur, Strahinja Odalovic, Jelena Petrovic, Nikola Pantic, Isidora Grozdic Milojevic, Dragana Sobic Saranovic, Predrag Sabljak, Vera Artiko","doi":"10.2478/raon-2026-0047","DOIUrl":"10.2478/raon-2026-0047","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate differences among three patient groups with suspected recurrent esophageal carcinoma, defined by <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT) findings, in quantitative and semiquantitative PET/CT parameters and serum tumor markers, and to assess their impact on progression-free survival (PFS) and overall survival (OS).</p><p><strong>Patients and methods: </strong>This retrospective cohort study included 77 patients with positive <sup>18</sup>F-FDG PET/CT findings between January 2014 and December 2025. Based on <sup>18</sup>F-FDG PET/CT findings, patients were classified into three groups: G1 (isolated locoregional recurrence), G2 (isolated metastases), and G3 (both locoregional disease and metastases). Semiquantitative and quantitative <sup>18</sup>F-FDG PET/CT parameters, histopathological characteristics, and blood tumor marker levels were compared among the groups. For survival analysis, patients were stratified into low and high groups according to the median value of each parameter.</p><p><strong>Results: </strong>Elevated carcinoembryonic antigen (CEA) levels were significantly more frequent in G2 and G3 compared with G1 (p = 0.005), while no significant difference was observed for carbohydrate antigen 19-9 (CA19-9) levels (p = 0.280). Significant differences in all analyzed <sup>18</sup>F-FDG PET/CT parameters were found among the three groups, with the highest values in G3. Patients with lower maximal standardized uptake values (SUVmax) and SUVmean values demonstrated significantly longer PFS and OS. Lower metabolic tumor volume (MTV) and total lesion glycolysis (TLG) values were associated with significantly longer progression-free survival (PFS), while overall survival (OS) was also longer, although without statistical significance.</p><p><strong>Conclusions: </strong>Studies stratifying patients by isolated locoregional recurrence, isolated metastases, and combined locoregional/metastases on <sup>18</sup>F-FDG PET/CT remain limited. Our findings suggest that disease spread patterns and semiquantitative/quantitative <sup>18</sup>F-FDG PET/CT parameters may provide important prognostic value in patients with esophageal carcinoma.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"346-355"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148901084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Timed saliva sampling as a new reliable marker for assessing iodine intake.","authors":"Adrijana Oblak, Jernej Imperl, Mitja Kolar, Gregor Marolt, Blaz Krhin, Katja Zaletel, Simona Gaberscek","doi":"10.2478/raon-2026-0045","DOIUrl":"10.2478/raon-2026-0045","url":null,"abstract":"<p><strong>Background: </strong>Iodine is an essential component of thyroid hormones. Therefore, sufficient iodine intake is important for adequate thyroid function. Measuring the urinary iodine concentration (UIC) is the recommended method for assessing population iodine intake, but it has certain drawbacks. In addition to urine, iodine is also excreted into saliva. Therefore, the aim of our work was to determine whether salivary iodine concentration (SLIC) measurement could replace UIC measurements, even a gold standard, urinary iodine excretion (UIE) in the 24-hour urine. We also evaluated the influence of saliva collection time on SLIC measurements.</p><p><strong>Subjects and methods: </strong>We invited adult volunteers who first provided 24-hour urine and saliva samples collected on the same day at home, strictly according to the protocol. UIC and SLIC before and after meals were measured using the Sandell-Kolthoff method, comparable to inductively coupled plasma mass spectrometry.</p><p><strong>Results: </strong>The study included 104 healthy participants from whom all biological samples were completely collected. Importantly, none of them was taking thyroid medication or iodine supplements and all were without thyroid disease. A very good correlation of SLIC values at 60 and 120 min after the first and second meal and 30 min after the second, third, and fourth meals with UIE was observed (P>0.05).</p><p><strong>Conclusions: </strong>We found an excellent correlation between SLIC values and UIE, where the SLIC value depends on the sampling timing and/or number of meals. SLIC measurement could replace UIE measurement and represents an important and possible new biomarker for assessing iodine intake.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"339-345"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13554299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148912723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}